AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 48 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $18,000 | -28.0% | 28,629 | 0.0% | 0.00% | – |
Q3 2019 | $25,000 | +25.0% | 28,629 | 0.0% | 0.00% | – |
Q2 2019 | $20,000 | -89.4% | 28,629 | -87.5% | 0.00% | – |
Q1 2019 | $189,000 | -48.6% | 229,659 | 0.0% | 0.00% | – |
Q4 2018 | $368,000 | -49.1% | 229,659 | +5.3% | 0.00% | – |
Q3 2018 | $723,000 | +46.7% | 218,129 | 0.0% | 0.00% | – |
Q2 2018 | $493,000 | +486.9% | 218,129 | +661.9% | 0.00% | – |
Q1 2018 | $84,000 | +5.0% | 28,629 | 0.0% | 0.00% | – |
Q4 2017 | $80,000 | +433.3% | 28,629 | +89.6% | 0.00% | – |
Q2 2016 | $15,000 | +7.1% | 15,100 | 0.0% | 0.00% | – |
Q1 2016 | $14,000 | -30.0% | 15,100 | 0.0% | 0.00% | – |
Q4 2015 | $20,000 | +5.3% | 15,100 | 0.0% | 0.00% | – |
Q3 2015 | $19,000 | -29.6% | 15,100 | 0.0% | 0.00% | – |
Q2 2015 | $27,000 | +22.7% | 15,100 | 0.0% | 0.00% | – |
Q1 2015 | $22,000 | +69.2% | 15,100 | 0.0% | 0.00% | – |
Q4 2014 | $13,000 | -23.5% | 15,100 | 0.0% | 0.00% | – |
Q3 2014 | $17,000 | -39.3% | 15,100 | 0.0% | 0.00% | – |
Q2 2014 | $28,000 | -76.7% | 15,100 | -81.1% | 0.00% | – |
Q1 2014 | $120,000 | -18.9% | 80,000 | 0.0% | 0.00% | – |
Q4 2013 | $148,000 | -11.4% | 80,000 | 0.0% | 0.00% | – |
Q3 2013 | $167,000 | -37.2% | 80,000 | -22.9% | 0.00% | -100.0% |
Q2 2013 | $266,000 | – | 103,797 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |